Point of Care Diagnostics: Technologies and Global Markets

Publish Date: May 2019 | Category: Healthcare, Pharmaceuticals & Medical Devices | Publisher: BCC Research | Status: Publish

The global market for point of care (POC) diagnostics and testing should grow from $19.3 billion in 2018 to $25.5 billion by 2023 with a compound annual growth rate (CAGR) of 5.7% from 2018 to 2023.

Report Scope:

This study will describe the market for POC diagnostics at the global level. It focuses on the accelerating growth in this important diagnostic market segment and the key industry players. Specifically, the report - 
- Describes the POC testing industry.
- Estimates the current and future market size.
- Provides breakdowns for U.S. markets.
- Describes product segments and the continuous updating of POC products.
- Analyzes market influences in the industry and predicts the changes that will shape the future POC testing market.
- Discusses trends within the market and provides a future outlook.
- Reviews business activities of market leaders.
- Lists patents for POC technologies.

Report Includes:

- 43 data tables and 19 additional tables
- An overview of the global markets for point of care (POC) diagnostics and testing within healthcare industry
- Analyses of global market trends, with data from 2017 and 2018, and projections of compound annual growth rates (CAGRs) through 2023
- A look at the diagnostic testing industry featuring current trends, government regulations and growth drivers that will shape the future POC testing market
- Assessment of competitive landscape and current product suppliers and some of their technologies and market shares within the POC industry
- Patent study and analysis covering all significant developments in POC technologies
- Company profiles of major global players within the POC market, including Abbott Laboratories, Beckman Coulter, Inc., Becton, Dickinson and Co., Danaher Corp., Roche and Siemens Medical Solutions

Summary

Globally, the diagnostic testing business is a multi-billion-dollar industry with intense competition and areas of high growth. The United States is the world’s largest single market for diagnostic testing. This study focuses on POC testing, which is one of the most active segments within the diagnostic industry. POC testing is growing in both home use and POC testing near-patient applications. Both segments are included in this market study.

In 2018, the global POC diagnostics market reached REDACTED. The market forecast shows continued recovery and increasing growth for many segments with an overall CAGR of REDACTED expected over a five-year period (2018-2023), reaching a market value of REDACTED by 2023.

Major Findings

- The list of CLIA (Clinical Laboratory Improvement Amendments) waived tests has expanded and opened new POC diagnostics segments. This waiver is for less complex laboratory tests and allows less qualified personnel to perform them.
- Moderate skill level tests used at the POC are also increasing, offering more options than ever to health providers.
- A major force driving the growth of this industry is the effort to provide better patient care by improving the turn-around-time (TAT) that POC testing offers.
- Other forces include cost containment through shorter time spent in the ER and other critical care environments, the aging population that requires proportionately greater healthcare, the increased incidence of certain diseases, health worker shortages, and technological advances allowing for small, portable, easy-to-use POC devices.
- Strategic alliances, mergers and acquisitions are allowing companies quick market entry into the POC segment; this trend is being fueled by the accelerating cost of product development.
- Glucose testing meters and supplies account for REDACTED of global POC sales in 2018. Although the worldwide incidence of diabetes is predicted to double in the next 25 years and the use of testing devices is expected to increase, pricing pressures will likely offset the majority of gains in unit sales.
- The global POC testing market is led by Roche, Johnson & Johnson, Alere, Abbott, Siemens and Danaher; these companies alone account for over REDACTED of global revenues.

Table of Contents

Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing the Study
Contribution of the Study and Intended Audience
Scope of Report
Defining POC Testing
Methodology
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter 2 Summary and Highlights
Overview
Major Findings

Chapter 3 Industry Overview
What is POC Testing?
Industry Terms
Overview of the POC Testing Market
POC as Part of the Clinical Diagnostics Industry Structure
Medical Benefits Derived from Immediate Diagnostic Testing
POC Testing Sites
Home Use/Self-Care
Emergency Rooms
Critical-Care Units
Bedside Testing
Operating Rooms/Procedure Rooms
Physicians' Offices/Clinics/Treatment Centers/Other Noncritical-Care Sites
Nursing Homes and Hospice
POC Product Segments
Blood Chemistry and Electrolytes
Cardiac Marker
Cholesterol Testing/Monitoring
Drug and Alcohol Screening
Glucose Testing and Monitoring
Infectious Disease Testing
Pregnancy and Fertility Testing
Hemoglobin and Hemostasis
Tumor Marker
Urinalysis/Urine Chemistry
Commonly Performed POC Tests
Multiplex POCT (xPOCT)
Significance of CLIA in the United States
The FDA's Role in POC Testing
Good Manufacturing Practice
Forces Driving the POC Testing Market
Cost Containment
Rising Healthcare Costs
Trends in Hospital Length of Stay
Public Healthcare Systems Around the World
Global Shortage of Healthcare Workers
Technological Advancements
Availability of Ease of Use Devices
New Technologies
Incidence of Disease
Asthma
Cardiovascular Disease
Cancer
Diabetes
Diarrheal Disease
HIV
Infertility
Influenza
Malaria
Pregnancy
Tuberculosis
Attention to Drugs of Abuse
Demographics and Aging Populations
Global Demographics
Global Life Expectancy
U.S. Demographics
Gender, Age and Life Expectancy

Chapter 4 The Global POC Testing Market
Market Overview
International Market Size
Global Market Revenues
North America
Europe
Asia-Pacific
LAAM
Presence of Manufacturers in the Worldwide Market
Competitor Market Share
Market Structure
Distribution
Promotion
Strategic Alliances and Mergers

Chapter 5 Market Segments
Overview
Blood Chemistry and Electrolyte Testing
Cardiac Marker Testing
Cholesterol Testing
Drug and Alcohol Abuse Testing
Glucose Testing
Infectious Disease Testing
Pregnancy and Fertility Testing
Hematology and Hemostasis Testing
Tumor Marker Testing
Urine Chemistry Testing
Miscellaneous POC Testing
Clinical Laboratory Improvement Amendments (CLIA)
Hematology
Chemistry
Alcohol and Drugs of Abuse
Endocrine
Infectious Disease and Immunology
Infectious Disease and Bacteriology
Infectious Disease and Parasitology
Infectious Disease and Virology
Urinalysis

Chapter 6 Blood Chemistry and Electrolyte Testing
Segment Overview
Blood Chemistry Parameters
Electrolytes
CLIA Quality Control Requirements for Blood Gas Analysis
Market Size
xPOCT Market Share
Market Participants and Market Shares
Abbott Diagnostics
Abaxis
Alere
International Technidyne Corp.
Nova Biomedical
Radiometer America Inc.
Roche Diagnostics
Siemens Healthcare

Chapter 7 Cardiac Marker Testing
Segment Overview
Market Size
xPOCT Market Share
Market Participants and Market Shares
Abbott
Alere
Roche
Response Biomedical
Siemens Healthcare

Chapter 8 Cholesterol Testing
Segment Overview
Market Size
xPOCT Market Share
Market Participants and Market Shares
Abaxis
Alere
Roche Diagnostics

Chapter 9 Drug and Alcohol Abuse Testing
Segment Overview
Market Size
xPOCT Market Share
Market Participants and Market Shares
Alere
Orasure Technologies
Phamatech

Chapter 10 Glucose Testing
Segment Overview
Market Size
xPOCT Market Share
Market Participants and Market Shares
Roche Diagnostics
Lifescan
Abbott Diabetes Care
Trevidia Health
Siemens

Chapter 11 Infectious Disease Testing
Segment Overview
Market Size
xPOCT Market Share
Market Participants and Market Shares
Specific Products for Testing
Strep A
Influenza
Chlamydia
Strep A
Influenza
Chlamydia/Trichomoniasis
RSV
HIV Testing
Infectious Mononucleosis
H. pylori
Herpes Simplex Virus
Syphilis Treponemal

Chapter 12 Pregnancy and Fertility Testing
Segment Overview
Market Size
xPOCT Market Share
Market Participants and Market Shares

Chapter 13 Hemoglobin/Hemostasis Testing
Hematology and Hemostasis
Hemostasis (Coagulation)
Market Size
xPOCT Market Share
Market Participants and Market Shares

Chapter 14 Tumor Marker Testing
Segment Overview
Fecal and Gastric Occult Blood
Bladder Tumor Antigen Test
Market Size
xPOCT Market Share
Market Participants and Market Shares
Beckman Coulter
Quidel
Alere

Chapter 15 Urine Chemistry Testing
Segment Overview
Market Size
xPOCT Market Share
Market Participants and Market Shares
Roche
Siemens

Chapter 16 Other POC Tests
Segment Overview
Vaginal pH Tests
Thyroid Stimulating Hormone Tests
Male Reproductive Tests
Menopause
Dry Eye
Market Size
xPOCT Market Share

Chapter 17 Patents

Chapter 18 Company Profiles
ABAXIS INC.
ABBOTT LABORATORIES
ALERE INC.
BECKMAN COULTER, INC.
BECTON, DICKINSON AND CO.
BIOMÉRIEUX SA
CHEMBIO DIAGNOSTICS, INC.
CHURCH & DWIGHT CO., INC.
DANAHER CORP.
ELITECH GROUP
HEMOCUE AB
ORTHO CLINICAL DIAGNOSTICS
MICRONICS INC.
NOVA BIOMEDICAL
ORASURE TECHNOLOGIES
PHAMATECH INC.
QUIDEL CORP.
RADIOMETER MEDICAL APS
ROCHE
SA SCIENTIFIC LTD.
SEKISUI DIAGNOSTICS
SAVYON DIAGNOSTICS
SIEMENS MEDICAL SOLUTIONS
TRIVIDIA HEALTH, INC.
TRINITY BIOTECH PLC
ZOETIS INC.

Choose License Type

Research Assistance

For Enquiries, Call :

+44-203-322-1521

Email : sales@trendsmarketresearch.com

Send Your Request